As of 2026-05-22, the Relative Valuation of Betta Pharmaceuticals Co Ltd (300558.SZ) is 20.95 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 48.83 CNY, the upside of Betta Pharmaceuticals Co Ltd based on Relative Valuation is -57.1%.
The range of the Relative Valuation is 19.23 - 25.44 CNY.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 24.3x | 20.4x |
| Forward P/E multiples | 14.7x - 18.3x | 15.8x |
| Fair Price | 19.23 - 25.44 | 20.95 |
| Upside | -60.6% - -47.9% | -57.1% |
| Date | P/E |
| 2026-05-20 | 46.57 |
| 2026-05-19 | 46.45 |
| 2026-05-18 | 46.72 |
| 2026-05-15 | 48.21 |
| 2026-05-14 | 47.78 |
| 2026-05-13 | 48.86 |
| 2026-05-12 | 50.45 |
| 2026-05-11 | 50.86 |
| 2026-05-08 | 49.06 |
| 2026-05-07 | 50.51 |
| 2026-05-06 | 50.50 |
| 2026-04-30 | 49.54 |
| 2026-04-29 | 45.94 |
| 2026-04-28 | 47.23 |
| 2026-04-27 | 47.19 |
| 2026-04-24 | 47.12 |
| 2026-04-23 | 47.59 |
| 2026-04-22 | 42.12 |
| 2026-04-21 | 41.96 |
| 2026-04-20 | 42.05 |
| 2026-04-17 | 42.03 |
| 2026-04-16 | 43.00 |
| 2026-04-15 | 43.58 |
| 2026-04-14 | 42.79 |
| 2026-04-13 | 41.58 |
| 2026-04-10 | 42.20 |
| 2026-04-09 | 42.07 |
| 2026-04-08 | 43.02 |
| 2026-04-07 | 42.42 |
| 2026-04-03 | 42.13 |
| 2026-04-02 | 43.61 |
| 2026-04-01 | 43.75 |
| 2026-03-31 | 41.58 |
| 2026-03-30 | 42.00 |
| 2026-03-27 | 41.28 |
| 2026-03-26 | 39.08 |
| 2026-03-25 | 40.13 |
| 2026-03-24 | 39.82 |
| 2026-03-23 | 38.43 |
| 2026-03-20 | 40.63 |
| 2026-03-19 | 41.33 |
| 2026-03-18 | 42.52 |
| 2026-03-17 | 41.61 |
| 2026-03-16 | 42.10 |
| 2026-03-13 | 41.25 |
| 2026-03-12 | 41.53 |
| 2026-03-11 | 41.94 |
| 2026-03-10 | 42.43 |
| 2026-03-09 | 41.44 |
| 2026-03-06 | 41.97 |